A novel molecular marker of breast cancer stem cells identified by cell-SELEX method

Cancer Biomarkers

Volumn 15, Issue 2, 2015, Pages 169-176

  Lu, Min ^a   Zhou, Lei ^a   Zheng, Xiaohui ^b   Quan, Yi ^c   Wang, Xiaoli ^a   Zhou, Xinna ^a   Ren, Jun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

aptamer; biomarker; Breast cancer; cancer stem cell; cell SELEX; SELEX

Indexed keywords

APTAMER; CD24 ANTIGEN; HERMES ANTIGEN; MOLECULAR MARKER; SALINOMYCIN; SINGLE STRANDED DNA; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER STEM CELL; CELL SELEX METHOD; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; CYTOCHEMISTRY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MCF 7 CELL LINE; PHENOTYPE; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; SHIFT TO THE RIGHT; TARGET CELL; BREAST TUMOR; CHEMISTRY; CONFORMATION; FEMALE; GENETICS; IMMUNOPHENOTYPING; METABOLISM; MULTICELLULAR SPHEROID; NUCLEOTIDE SEQUENCE; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE; TUMOR CELL CULTURE; TUMOR CELL LINE;

ANTIGENS, CD24; ANTIGENS, CD44; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; NEOPLASTIC STEM CELLS; NUCLEIC ACID CONFORMATION; PHENOTYPE; SELEX APTAMER TECHNIQUE; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84925351928     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-140450     Document Type: Article

References (41)

1. R. Siegel, D. Naishadham, A. Jemal, Cancer statistics, 2013, CA Cancer J Clin 63 (2013) 11-30.
2. T. Reya, S.J. Morrison, M.F. Clarke, I.L. Weissman, Stem cells, cancer, and cancer stem cells, Nature 414 (2001) 105-111.
3. C.E. Eyler, J.N. Rich, Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis, J Clin Oncol 26 (2008) 2839-2845.
4. X. Li, M.T. Lewis, J. Huang, C. Gutierrez, C.K. Osborne, M.F. Wu, S.G. Hilsenbeck, A. Pavlick, X. Zhang, G.C. Chamness, H.Wong, J. Rosen, J.C. Chang, Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy, J Natl Cancer Inst 100 (2008) 672-679.
5. W.A. Woodward, M.S. Chen, F. Behbod, M.P. Alfaro, T.A. Buchholz, J.M. Rosen, WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells, Proc Natl Acad Sci U S A 104 (2007) 618-623.
6. M. Diehn, R.W. Cho, N.A. Lobo, T. Kalisky, M.J. Dorie, A.N. Kulp, D. Qian, J.S. Lam, L.E. Ailles, M. Wong, B. Joshua, M.J. Kaplan, I. Wapnir, F.M. Dirbas, G. Somlo, C. Garberoglio, B. Paz, J. Shen, S.K. Lau, S.R. Quake, J.M. Brown, I.L. Weissman, M.F. Clarke, Association of reactive oxygen species levels and radioresistance in cancer stem cells, Nature 458 (2009) 780-783.
7. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J.Morrison, M.F. Clarke, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci U S A 100 (2003) 3983-3988.
8. C. Ginestier, M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, M. Brown, J. Jacquemier, P. Viens, C.G. Kleer, S. Liu, A. Schott, D. Hayes, D. Birnbaum, M.S. Wicha, G. Dontu, ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome, Cell Stem Cell 1 (2007) 555-567.
9. S. Singh, B.S. Dwarakanath, T.L. Mathew, DNA ligand Hoechst-33342 enhances UV induced cytotoxicity in human glioma cell lines, J Photochem Photobiol B 77 (2004) 45-54.
10. D. Ponti, A. Costa, N. Zaffaroni, G. Pratesi, G. Petrangolini, D. Coradini, S. Pilotti, M.A. Pierotti, M.G. Daidone, Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties, Cancer Res 65 (2005) 5506-5511.
11. A. Hadnagy, L. Gaboury, R. Beaulieu, D. Balicki, SP analysis may be used to identify cancer stem cell populations, Exp Cell Res 312 (2006) 3701-3710.
12. A.D. Ellington, J.W. Szostak, In vitro selection of RNA molecules that bind specific ligands, Nature 346 (1990) 818-822.
13. C. Tuerk, L. Gold, Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase, Science 249 (1990) 505-510.
14. K.Y. Wang, L. Gerena, S. Swaminathan, P.H. Bolton, Determination of the number and location of the manganese binding sites of DNA quadruplexes in solution by EPR and NMR, Nucleic Acids Res 23 (1995) 844-848.
15. X.B. Zhang, Z. Wang, H. Xing, Y. Xiang, Y. Lu, Catalytic and molecular beacons for amplified detection of metal ions and organic molecules with high sensitivity, Anal Chem 82 (2010) 5005-5011.
16. X. Zhang, V.K. Yadavalli, Molecular interaction studies of vascular endothelial growth factor with RNA aptamers, Analyst 135 (2010) 2014-2021.
17. J. Huang, Y. Chen, L. Yang, Z. Zhu, G. Zhu, X. Yang, K. Wang, W. Tan, Amplified detection of cocaine based on strand-displacement polymerization and fluorescence resonance energy transfer, Biosens Bioelectron 28 (2011) 450-453.
18. M.C. Estevez, Y.F. Huang, H. Kang, M.B. O'Donoghue, S. Bamrungsap, J. Yan, X. Chen, W. Tan, Nanoparticle-aptamer conjugates for cancer cell targeting and detection, Methods Mol Biol 624 (2010) 235-248.
19. D. Shangguan, L. Meng, Z.C. Cao, Z. Xiao, X. Fang, Y. Li, D. Cardona, R.P. Witek, C. Liu, W. Tan, Identification of liver cancer-specific aptamers using whole live cells, Anal Chem 80 (2008) 721-728.
20. K. Sefah, L. Meng, D. Lopez-Colon, E. Jimenez, C. Liu, W. Tan, DNA aptamers as molecular probes for colorectal cancer study, PLoS One 5 (2010) e14269.
21. K. Zhang, K. Sefah, L. Tang, Z. Zhao, G. Zhu, M. Ye, W. Sun, S. Goodison, W. Tan, A novel aptamer developed for breast cancer cell internalization, Chem Med Chem 7 (2012) 79-84.
22. D. Van Simaeys, D. Lopez-Colon, K. Sefah, R. Sutphen, E. Jimenez, W. Tan, Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX, PLoS One 5 (2010) e13770.
23. J.C. Graham, H. Zarbl, Use of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cells, PLoS One 7 (2012) e36103.
24. A.T. Bayrac, K. Sefah, P. Parekh, C. Bayrac, B. Gulbakan, H.A. Oktem, W. Tan, In vitro Selection of DNA Aptamers to Glioblastoma Multiforme, ACS Chem Neurosci 2 (2011) 175-181.
25. Z. Tang, P. Parekh, P. Turner, R.W. Moyer, W. Tan, Generating aptamers for recognition of virus-infected cells, Clin Chem 55 (2009) 813-822.
26. Y.S. Kim, M.Y. Song, J. Jurng, B.C. Kim, Isolation and characterization of DNA aptamers against Escherichia coli using a bacterial cell-systematic evolution of ligands by exponential enrichment approach, Anal Biochem 436 (2013) 22-28.
27. M. Labib, A.S. Zamay, O.S. Kolovskaya, I.T. Reshetneva, G.S. Zamay, R.J. Kibbee, S.A. Sattar, T.N. Zamay, M.V. Berezovski, Aptamer-based impedimetric sensor for bacterial typing, Anal Chem 84 (2012) 8114-8117.
28. N. Savory, D. Lednor, K. Tsukakoshi, K. Abe, W. Yoshida, S. Ferri, B.V. Jones, K. Ikebukuro, In silico maturation of binding-specificity of DNA aptamers against Proteus mirabilis, Biotechnol Bioeng 110 (2013) 2573-2580.
29. F. Chen, Y. Hu, D. Li, H. Chen, X.L. Zhang, CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2, PLoS One 4 (2009) e8142.
30. J.H. Lee, M.D. Canny, A. De Erkenez, D. Krilleke, Y.S. Ng, D.T. Shima, A. Pardi, F. Jucker, A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165, Proc Natl Acad Sci U S A 102 (2005) 18902-18907.
31. H.W. Chen, C.D. Medley, K. Sefah, D. Shangguan, Z. Tang, L. Meng, J.E. Smith, W. Tan, Molecular recognition of small-cell lung cancer cells using aptamers, Chem Med Chem 3 (2008) 991-1001.
32. G. Liu, X. Mao, J.A. Phillips, H. Xu, W. Tan, L. Zeng, Aptamer-nanoparticle strip biosensor for sensitive detection of cancer cells, Anal Chem 81 (2009) 10013-10018.
33. Y.F. Huang, D. Shangguan, H. Liu, J.A. Phillips, X. Zhang, Y. Chen, W. Tan, Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells, Chembiochem 10 (2009) 862-868.
34. P.J. Bates, D.A. Laber, D.M. Miller, S.D. Thomas, J.O. Trent, Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer, Exp Mol Pathol 86 (2009) 151-164.
35. E.W. Ng, D.T. Shima, P. Calias, E.T. Cunningham, Jr., D.R. Guyer, A.P. Adamis, Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease, Nat Rev Drug Discov 5 (2006) 123-132.
36. P.B. Gupta, T.T. Onder, G. Jiang, K. Tao, C. Kuperwasser, R.A. Weinberg, E.S. Lander, Identification of selective inhibitors of cancer stem cells by high-throughput screening, Cell 138 (2009) 645-659.
37. G. Dontu, W.M. Abdallah, J.M. Foley, K.W. Jackson, M.F. Clarke, M.J. Kawamura, M.S. Wicha, In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells, Genes Dev 17 (2003) 1253-1270.
38. Y.Quan, Y.Yan, X. Wang, Q. Fu, W. Wang, J. Wu, G. Yang, J. Ren, Y. Wang, Impact of cell dissociation on identification of breast cancer stem cells, Cancer Biomark 12 (2012) 125-133.
39. K. Sefah, D. Shangguan, X. Xiong, M.B. O'Donoghue, W. Tan, Development of DNA aptamers using Cell-SELEX, Nat Protoc 5 (2010) 1169-1185.
40. Y. Kim, Q. Wu, P. Hamerlik, M. Hitomi, A.E. Sloan, G.H. Barnett, R.J. Weil, P. Leahy, A.B. Hjelmeland, J.N. Rich, Aptamer Identification of Brain Tumor-Initiating Cells, Cancer Res 73 (2013) 4923-4936.
41. K. Sefah, K.M. Bae, J.A. Phillips, D.W. Siemann, Z. Su, S. McClellan, J. Vieweg, W. Tan, Cell-based selection provides novel molecular probes for cancer stem cells, Int J Cancer 132 (2013) 2578-2588.